The fully integrated biopharma company Merrimack appointed a new president and CEO: Richard Peters, M.D., Ph.D.. He additionally became a member of Merrimack Pharmaceuticals’ board of directors.

Bayer appointed Dr. Carsten Brunn as president of its Pharmaceuticals business in the Americas, comprising the United States, Canada, Central America, and Latin America. In this role, Dr. Brunn reports to Dieter Weinand, member of the board of management of Bayer AG and president of the Pharmaceutical division.

Mathias Schmidt, Ph.D., has been named CEO of ArmaGen Inc. He also becomes a member of ArmaGen’s board of directors.

Eric Simmerman is now the first chief technology officer for HealthPrize Technologies.

Jean-Marie Cuillerot, M.D., has been appointed chief medical officer of Agenus Inc. Dr. Cuillerot initially joined Agenus in 2016 as VP and Global Head of Clinical Development.

Jeffrey Young has become chief financial officer, treasurer, and secretary of Juniper Therapeutics Inc.

Two VPs have been named at TGaS Advisors. Tom Goga has been named to lead Field Operations, which also includes Incentive Compensation, and Rich Waite will head Commercial Learning & Development.

Responding to demands from cities across the country, NYU School of Medicine’s Department of Population Health, NYU’s Robert F. Wagner School of Public Service and the National Resource Network – with support from the Robert Wood Johnson Foundation – have launched the City Health Dashboard.

Purdue Pharma LP, Virginia Governor Terry McAuliffe, and the Virginia Secretary of Health and Human Resources have announced the formation of a private-public partnership to enhance utilization of the state prescription monitoring program as part of the solution to address the opioid crisis.